MedTrace Logo

Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes

NCT05885646 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-06-15

No results posted yet for this study

Summary

The effect of sulthiame on EEG has been studied in epilepsy syndromes of childhood with sleep activation by comparing sleep EEG obtained at baseline and after 4 weeks of treatment. The aim of the study is to know if an effect is still identifiable after 2 weeks of treatment by performing sleep EEG recordings after 2 and 4 weeks of treatment, respectively.

Conditions

  • Importance of Interictal Epileptiform Activity on Sleep EEG
  • Epilepsy in Children

Interventions

DRUG

Sulthiame

Sulthiame add-on according to good clinical practice in these childhood epilepsy syndromes

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Patrick Van Bogaert, Professor · Angers University Hospital

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05885646 on ClinicalTrials.gov